Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03231241 · ClinicalTrials.gov registry record
Analysis of Headache Chronification With Imaging, Deep Phenotyping, and Proteomics
A clinical trial of Chronic Migraine and Chronic Daily Headache, sponsored by Stanford University.
- Recruiting
- Registry status
- 700
- Enrollment target
- 1
- Study location
NCT03231241: Recruiting study of Chronic Migraine and Chronic Daily Headache, sponsored by Stanford University.
NCT03231241 is a study of Chronic Migraine and Chronic Daily Headache that is actively recruiting participants, run by Stanford University. The registered enrollment target is 700 participants, above the 302-participant average among 17 other Chronic Migraine trials with a reported enrollment target (132% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03231241, a study of Chronic Migraine and Chronic Daily Headache, is actively recruiting participants, sponsored by Stanford University.
- RECRUITING
- Registry status
- 700 participants
- Enrollment target
- 1
- Study location
Study Summary
Study is aimed at determining why some patients with episodic headache proceed to chronic daily or near daily headaches. The Investigators seek to discover differences in brain anatomy and function, composition of cerebrospinal fluid, blood products, genetics, and patient phenotypes that might help explain this process.
Primary Outcome
Brain Imaging, Phenotyping and Proteomics data will be combined to learn headache mechanisms.
Conditions Studied
Study Locations (1)
California
- Stanford University School of Medicine - Stanford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 700 participants |
| Start Date | 2014-12-12 |
| Est. Completion | 2026-09-01 |
What NCT03231241 shows while recruiting
NCT03231241 is an observational study that tracks outcomes without assigning an intervention. The registered 700 participants enrollment target is mid-sized for trials with a published cap, above the 302-participant average among 17 other Chronic Migraine trials with a reported enrollment target (132% higher).
The record links to 2 conditions, with Chronic Migraine appearing as the primary indexed condition, and to 0 interventions.
NCT03231241 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT03231241 about?
NCT03231241 is a clinical study titled "Analysis of Headache Chronification With Imaging, Deep Phenotyping, and Proteomics". Study is aimed at determining why some patients with episodic headache proceed to chronic daily or near daily headaches. The Investigators seek to discover differences in brain anatomy and function, composition of cerebrospinal fluid, blood products, genetics, and patient phenotypes that might help ...
What is the current status of trial NCT03231241?
This trial is currently recruiting. The enrollment target is 700 participants. The study started on 2014-12-12. Estimated completion is 2026-09-01.
What conditions does trial NCT03231241 study?
This clinical trial studies the following conditions: Chronic Migraine, Chronic Daily Headache.
Who is sponsoring clinical trial NCT03231241?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03231241 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Migraine
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03231241's enrollment target sits among peer trials
700 4th of 17 higher than 14 of 17 other Chronic Migraine trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Chronic Migraine trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
BOTOX® vs. XEOMIN® for Chronic Migraine
RECRUITING · Phase 3
-
Responding With Evidence and Access for Childhood Headaches
RECRUITING · NA
-
Determining the Utility of a Behavioral Intervention in Chronic Migraine
RECRUITING · NA
-
Assessing Symptom and Mood Dynamics in Pain Using the Smartphone Application SOMA
RECRUITING
-
Investigation and Modulation of the Central Mu-Opioid Mechanism in Migraine (in Vivo)
RECRUITING · NA
-
Acceptance and Commitment Therapy to Improve Disability in Chronic Migraine
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00900419 · 700 participants
Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal Volunteers
- NCT01804686 · 700 participants · Phase 3
A Long-term Extension Study of PCI-32765 (Ibrutinib)
- NCT02107989 · 700 participants
Noninvasive Pre-surgical Evaluation of Patients With Focal Epilepsy and Establishment of a Normative Imaging Database
- NCT02129543 · 700 participants
Immune Reconstitution in Stem Cell Transplant Recipients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI